MedCity News

JULY 12, 2023

That’s why I left traditional medicine. Providers just aren’t given the time it takes to build rapport and ask the right questions within the fee-for-service model. Providers like me who now work in an employer healthcare model can truly help people versus treating them reactively.

Healthcare 244

Healthcare Healthcare Leads Patients 244

Fierce Pharma

MAY 1, 2024

Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen. Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen.

Marketing 268

Marketing Sales Medicine Leads 268

European Pharmaceutical Review

MAY 22, 2024

The agencies holding this status have been approved and validated as compliant and committed to upholding the “highest level of regulatory standards and practices for quality, safety and efficacy of medicines and vaccines ”.

Medicine 93

Medicine Leads Food and Drug Administration Safety 93

MedCity News

FEBRUARY 3, 2023

Much of the new cash will support its lead program, an oral small molecule that could weigh in on the diabetes and obesity indications currently dominated by blockbuster injectable medicines. Despite challenging financial market conditions, clinical-stage Structure Therapeutics was able to upsize its IPO.

Medicine 298

Medicine Leads Marketing Biopharma 298

MedCity News

AUGUST 1, 2024

Otsuka Pharmaceutical is acquiring Jnana Therapeutics, whose lead drug is a potential treatment for the rare metabolic disorder phenylketonuria (PKU). Jnana’s drug could provide an alternative to two FDA-approved PKU medicines from BioMarin Pharmaceutical.

Pharmaceutical 273

Pharmaceutical Medicine FDA Leads 273

MedCity News

JULY 25, 2022

Private equity firm KKR teamed up with OMX Ventures to lead the seed investment in Replay, a company developing a suite of technologies that could overcome capacity limitations of adeno-associated viruses used for genetic medicines delivery. Duchenne muscular dystrophy is among the disease targets of the new startup.

Medicine 289

Medicine Leads Biopharma Pharma 289

MedCity News

AUGUST 11, 2022

After receiving European Medicines Agency feedback for its lead program for a rare eye disorder, the biotech has decided to find a strategic partner for all of its eye drug assets and apply its RNA technology to other therapeutic areas. RNA therapies developer ProQR Therapeutics is eying a future without ophthalmology.

Medicine 288

Medicine Leads Biopharma Pharma 288

Fierce Pharma

OCTOBER 10, 2023

Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies.

Prospecting 265

Prospecting Manufacturing Medicine Leads 265

PharmaVoice

JULY 28, 2022

The digital medicine company’s chief strategy officer, John Varaklis, explains how its analytic predictive platform could lead to safer and quicker clinical trials.

Medicine 246

Medicine Leads 246

MedCity News

JANUARY 21, 2024

The FDA said Amgen’s Prolia may lead to low levels of calcium, or hypocalcemia. The osteoporosis drug’s black box warning follows an FDA review of Centers for Medicare & Medicaid Services studies that found Prolia led to a significant increase in the risk of severe hypocalcemia compared to treatment with an older class of medicines.

FDA 264

FDA Medicine Leads Biopharma 264

MedCity News

OCTOBER 12, 2022

Ascidian Therapeutics is developing therapies for inherited disorders that work by editing RNA with an approach that could offer advantages over currently available genetic medicines. The biotech’s lead program is in preclinical development for Stargardt disease, a rare eye disorder caused by multiple genetic mutations.

Medicine 245

Medicine Leads Biopharma Pharma 245

World of DTC Marketing

JUNE 5, 2021

There is disagreement whether obesity is really considered a disease or a behavioral risk factor, similar to smoking, alcohol, and substance abuse that may lead to disease. Some of the environmental conditions that lead to obesity are physical activity, alcohol consumption, socioeconomic status, parent feeding behavior, and diet.

Government 193

Government Medicine Food Management 193

Fierce Pharma

SEPTEMBER 20, 2024

Europe’s Committee for Medicinal Products for Human Use has confirmed its negative stance on pegcetacoplan in geographic atrophy, an advanced form of age-related macular degeneration that can lead to blindness. This marks the third rejection this year for pegcetacoplan in Europe.

Prospecting 221

Prospecting Medicine Leads Pharmaceutical 221

pharmaphorum

APRIL 29, 2024

George Medicines has appointed former Ironwood CEO Mark Mallon to lead the company as it tries to get its triple therapy for hypertension over the finish line.

Medicine 105

Medicine Leads 105

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 122

Medicine Management Marketing Leads 122

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. In this Q&A, EPR caught up with CEO James Short and Managing Director Arthur Wakeley from Celadon, to learn more about the company’s experience moving through, and progressing, the strict regulatory process for medicinal cannabis.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

Pharmaceutical Technology

JANUARY 16, 2023

CARsgen Therapeutics has announced a col labor ation with Huadong Medicine to commercialise zevorcabtagene autoleucel (zevor-cel), CT053, in mainland China. Under the collaboration, Huadong Medicine will have the exclusive right to commercialise CARsgen’s CT053 in mainland China.

Medicine 119

Medicine Food and Drug Administration Food Medical 119

European Pharmaceutical Review

MAY 2, 2024

Two trends that I expect to continue in the foreseeable future are the move towards precision medicine and the diversification of the biologics chemical structures. There have been upward of 1,900 precision medicine clinical trials conducted to date. Available from: [link] The post What is the future of biologic medicines?

Medicine 105

Medicine Manufacturing Biopharma Engineering 105

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology. Optimise your cell therapy process: a guide to cell thawing.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

MedCity News

JULY 27, 2023

However, one-size-fits-all solutions have disadvantages in medicine today. Current applications Today, there is an escalated appetite to address emerging procedures because they offer an opportunity for device makers – and physicians like me who are interested in cutting-edge technology – to influence new areas of medicine.

Specialization 241

Specialization Medical Medicine Leads 241

MedCity News

JANUARY 30, 2024

With the rise of AI technologies, we could see significant advancements in cancer treatment, making it more efficient and potentially leading to a cure. By analyzing vast amounts of data from medical records, laboratory tests and imaging scans, AI algorithms can provide a more precise diagnosis, which can lead to better treatment outcomes.

Side effects 325

Side effects Ethics Medical Patients 325

European Pharmaceutical Review

FEBRUARY 22, 2024

This is “an important milestone” according to Lynn Clay, Specialty Care Lead at Pfizer UK. However, on 31 October 2023, a marketing authorisation in Great Britain was granted for the medicine ritlecitinib. “It The post NICE recommends first medicine for severe alopecia areata appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Leads Healthcare Healthcare 98

Fierce Pharma

NOVEMBER 1, 2023

In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky talks with the study lead, Reisa Sperling, M.D., to learn more.

Medicine 172

Medicine Leads 172

European Pharmaceutical Review

OCTOBER 22, 2024

The UK is set to be the first country to introduce a new regulatory framework for innovative products manufactured at or close to the point of patient care, says the Medicines and Healthcare products Regulatory Agency (MHRA). Introduction of this framework was originally announced by the MHRA in January 2023.

Medicine 89

Medicine Manufacturing Safety Consulting 89

Fierce Pharma

JUNE 6, 2024

Amid a nuclear medicine boom, France’s Orano Med has chosen the U.S. The site marks the world’s first industrial-scale facility dedicated to production of lead-212-based radioligand therapies, the company said. to establish a manufacturing plant as it progresses on its radiopharma journey.

Manufacturing 178

Manufacturing Medicine Leads 178

PM360

JANUARY 7, 2025

Acquisition highlights companies shared commitment to clients, workplace culture, and attracting the industrys best people TORONTO, ON/SARATOGA SPRINGS, NY January 7, 2025 Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.

Marketing 52

Marketing Leads Medical Consulting 52

European Pharmaceutical Review

NOVEMBER 15, 2023

[Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. The post Sandoz mobilises critical medicine production in Europe appeared first on European Pharmaceutical Review.

Medicine 93

Medicine Manufacturing Networking Biopharma 93

World of DTC Marketing

FEBRUARY 17, 2022

But it’s still the leading cause of cancer deaths. Although lung cancer’s mortality rate has fallen, the disease is still the leading cause of cancer deaths. According to a team of Penn State College of Medicine researchers, care for the 15 most prevalent types of cancer in the U.S. American Cancer Society’s ACS ).

Medicine 271

Medicine Insurance Leads Medical 271

Evolve Your Success

NOVEMBER 14, 2023

One of those is sports medicine. As we celebrate International Men’s Day, Samuel Adeyinka interviews Jordan Rawlins about the world of orthopedics, namely sports medicine. What are the different roles in sports medicine medical sales and what do you need to prepare to ensure success in this space? What are you selling?

Medical sales 130

Medical sales Medicine Sales Medical 130

European Pharmaceutical Review

DECEMBER 4, 2024

A new report, ‘ Enhancing the role of UK medicine regulation ’ by the Association of the British Pharmaceutical Industry (ABPI) explores the key role that regulatory excellence has in driving innovation and early treatment access for patients, as well bringing investment into the UK.

Competition 52

Competition Medicine Leads Pharmaceutical 52

MedCity News

OCTOBER 13, 2023

The National Institute on Aging also added a startup boot camp leading up to HLTH. Health tech to support care for seniors and track the progression of conditions such as Parkinson’s disease and heart failure were on display at HLTH 2023.

Leads 306

Leads Medicine 306

European Pharmaceutical Review

JANUARY 11, 2024

What are the key current challenges in the development of pain medicines? What is the present clinical landscape for pain management medicines, especially chronic pain? Pain management therapies: Pfizer’s migraine medicine recommended by NICE What are three current development trends for pain management treatments?

Medicine 102

Medicine Pharmacology Management Side effects 102

European Pharmaceutical Review

DECEMBER 22, 2022

Advances in mRNA technologies and cellular delivery systems coupled with their cost effectiveness, manufacturing simplicity and ability to target previously-undruggable pathways has limitless potential that could revolutionise medicine. 2022) The Progress and Promise of RNA Medicine – An Arsenal of Targeted Treatments. References.

Medicine 116

Medicine Food and Drug Administration Transportation Distribution 116

World of DTC Marketing

OCTOBER 21, 2021

SUMMARY: Medicare spent nearly $600 million over a three-year period to pay for four cancer drugs with no clinical benefit an analysis published Monday by JAMA Internal Medicine found. Between 2011 and 2018, cumulative spending on 44 FDA-approved oral targeted therapy drugs was $3.5

FDA 234

FDA Insurance Prescription Medicine 234

Infuse Medical

FEBRUARY 4, 2025

Difficulty in Mastering Complex Procedures The complexity of modern medical devices and procedures often leads to steep learning curves. Consider a newly introduced robotic surgical system: without comprehensive training, even experienced surgeons may struggle to master its nuances, leading to longer procedures and potential complications.

Training 130

Training Medical Healthcare Healthcare 130

PharmaVoice

APRIL 30, 2024

From resurrecting an extinct species to improving regenerative medicines with plant-based materials, these biotechs are on the leading edge of science.

Medicine 130

Medicine Leads 130

World of DTC Marketing

JULY 31, 2021

Whenever possible, I have tried to share information from leading physicians to help others understand exactly what’s going on. He is Chair of UCSF Department of Medicine and has been actively sharing his thoughts on the latest COVID information. Take, for example, Dr. Bob Wachter.

Media 253

Media Doctors Physicians Medicine 253